A Case of Erythrodermic Psoriasis Successfully Treated with Risankizumab
Clin Cosmet Investig Dermatol. 2023 Dec 5;16:3503-3507. doi: 10.2147/CCID.S447123. eCollection 2023.ABSTRACTPsoriasis is a chronic inflammatory cutaneous disease, affecting up to 3% of the worldwide population. Several clinical phenotypes can be distinguished. Among these, erythrodermic psoriasis (EP) is a rare and severe variant (less than 3% of cases), characterized by severe generalized erythema and scaling affecting at least 90% of the body surface area. EP is often a life-threatening condition, since several systemic symptoms (tachycardia, fever, fatigue, lymphadenopathy, dehydration, serum electrolyte disturbances) c...
Source: Clinical, Cosmetic and Investigational Dermatology - December 11, 2023 Category: Dermatology Authors: Matteo Megna Angelo Ruggiero Antonia Salsano Giuseppe Lauletta Antonio Portarapillo Ginevra Torta Fabrizio Martora Luca Potestio Source Type: research
Effect of Stanozolol combined with Cyclosporine A on aplastic anemia
CONCLUSION: Stanozolol combined with Cyclosporine A is more effective than Stanozolol alone in treatment of aplastic anemia.PMID:38074827 | PMC:PMC10703648 (Source: American Journal of Translational Research)
Source: American Journal of Translational Research - December 11, 2023 Category: Research Authors: Weiwei Zhu Yue Ma Xin Li Tianjie Han Lijun Li Zhirui Zhao Zhe Yu Source Type: research
